The Impact of Pharmacological Targeting of Abnormal Tumor Metabolism with 3-Bromopyruvate on Dendritic Cell Mediated Tumoral Immunity
Studies have shown that tumor cells are susceptible to pharmacological targeting of their altered glycolytic metabolism with a variety of compounds that result in apoptosis. One such compound, 3-bromopyruvate (3-BP), has been shown to eradicate cancer in an animal model. However, no studies have...
| Other Authors: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Florida Atlantic University
|
| Subjects: | |
| Online Access: | http://purl.flvc.org/fau/fd/FA00004834 |